← Back to Search

Behavioral Intervention

Digital Intervention for Suicide Prevention

N/A
Waitlist Available
Led By Stephanie Stepp
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Youth: 12-17 years old
Be younger than 18 years old
Must not have
Youth: Other condition from medical history that would prohibit comprehension of questions or modules
Youth: Pervasive developmental disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to address the growing issue of suicidal thoughts and behaviors among teenagers. The study will test a digital suicide prevention intervention that can be used by pediatricians in primary care settings. If successful,

Who is the study for?
This trial is for young people who are experiencing depression, suicidal thoughts or behaviors, or have engaged in self-harm. It's aimed at those who could benefit from suicide prevention strategies within pediatric primary care settings.
What is being tested?
The study is testing a digital suicide prevention tool called iCHART/cASAP against the standard treatment usually given. The goal is to see if this new method can help reduce the risk of suicide among adolescents in a primary care environment.
What are the potential side effects?
Since this trial involves a digital intervention rather than medication, traditional side effects are not applicable. However, there may be emotional or psychological impacts from discussing sensitive topics like suicidal thoughts and behaviors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 17 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I can understand and answer questions about my health.
Select...
I have been diagnosed with a developmental disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Application utilization
Depression Severity
+7 more
Secondary study objectives
Stress

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: iCHART/cASAPExperimental Treatment1 Intervention
An intervention previously studied in the ETUDES Center along with a computerized version of our As Safe As Possible intervention. 1. Safety Planning App for suicidal youth which enables a primary care provider to streamline the gold standard of care for those with current suicidality symptoms through an app; 2. Mental Health Screener questionnaire that gathers additional mental health symptoms, treatment preferences, and family's readiness for treatment engagement to help a primary care provider make a personalized, tailored treatment plan a suicidal youth is more likely to adhere to; 3. Text Messages which aims to provide texts for 2-3 weeks to motivate you to engage with the safety plan and recommended treatment following the patient visit. 4. cASAP is a computerized version of the As Safe As Possible intervention that offers self-led modules with psychoeducation about safety planning, cognitive-behavioral skills to cope with distress, and facilitate collaboration with parents.
Group II: Treatment as usualActive Control1 Intervention
When patients disclose suicidal ideation on the PHQ-9, a treatment as usual approach will be given to the patient and their parent by the pediatrician which includes a paper safety plan will be completed and given to the patient and a referral placed for the patient to begin behavioral health services.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,908 Previous Clinical Trials
2,739,023 Total Patients Enrolled
698 Trials studying Depression
260,916 Patients Enrolled for Depression
University of PittsburghLead Sponsor
1,783 Previous Clinical Trials
16,357,131 Total Patients Enrolled
122 Trials studying Depression
34,409 Patients Enrolled for Depression
Pediatric Research in Office SettingsNETWORK
1 Previous Clinical Trials
1,872 Total Patients Enrolled
~40 spots leftby May 2026